Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.
Atar D, Arheden H, Berdeaux A, Bonnet JL, Carlsson M, Clemmensen P, Cuvier V, Danchin N, Dubois-Randé JL, Engblom H, Erlinge D, Firat H, Halvorsen S, Hansen HS, Hauke W, Heiberg E, Koul S, Larsen AI, Le Corvoisier P, Nordrehaug JE, Paganelli F, Pruss RM, Rousseau H, Schaller S, Sonou G, Tuseth V, Veys J, Vicaut E, Jensen SE. Atar D, et al. Among authors: paganelli f. Eur Heart J. 2015 Jan 7;36(2):112-9. doi: 10.1093/eurheartj/ehu331. Epub 2014 Sep 1. Eur Heart J. 2015. PMID: 25179768 Clinical Trial.
Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism.
Saadjian AY, Gerolami V, Giorgi R, Mercier L, Berge-Lefranc JL, Paganelli F, Ibrahim Z, By Y, Guéant JL, Lévy S, Guieu RP. Saadjian AY, et al. Among authors: paganelli f. Eur Heart J. 2009 Jun;30(12):1510-5. doi: 10.1093/eurheartj/ehp126. Epub 2009 Apr 21. Eur Heart J. 2009. PMID: 19386617
Value of a new multiparametric score for prediction of microvascular obstruction lesions in ST-segment elevation myocardial infarction revascularized by percutaneous coronary intervention.
Amabile N, Jacquier A, Gaudart J, Sarran A, Shuaib A, Panuel M, Moulin G, Bartoli JM, Paganelli F. Amabile N, et al. Among authors: paganelli f. Arch Cardiovasc Dis. 2010 Oct;103(10):512-21. doi: 10.1016/j.acvd.2010.09.005. Epub 2010 Nov 20. Arch Cardiovasc Dis. 2010. PMID: 21130964 Free article.
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson CM, Kovar F, Kala P, Garcia-Hernandez A, Renfurm RW, Granger CB; RUBY-1 Investigators. Steg PG, et al. Eur Heart J. 2011 Oct;32(20):2541-54. doi: 10.1093/eurheartj/ehr334. Epub 2011 Aug 30. Eur Heart J. 2011. PMID: 21878434 Free PMC article. Clinical Trial.
High on treatment platelet reactivity.
Ait-Mokhtar O, Bonello L, Benamara S, Paganelli F. Ait-Mokhtar O, et al. Among authors: paganelli f. Heart Lung Circ. 2012 Jan;21(1):12-21. doi: 10.1016/j.hlc.2011.08.069. Epub 2011 Oct 13. Heart Lung Circ. 2012. PMID: 22000771 Review.
COMparison of Platelet reactivity following prAsugrel and ticagrelor loading dose in ST-Segment elevation myocardial infarctION patients: The COMPASSION study.
Laine M, Gaubert M, Frère C, Peyrol M, Thuny F, Yvorra S, Chelini V, Bultez B, Luigi S, Mokrani Z, Bessereau J, Toesca R, Champenois A, Dignat-George F, Paganelli F, Bonello L. Laine M, et al. Among authors: paganelli f. Platelets. 2015;26(6):570-2. doi: 10.3109/09537104.2014.959914. Epub 2014 Oct 2. Platelets. 2015. PMID: 25275609
349 results